ECSP024399A - Derivados de benzotiazol - Google Patents
Derivados de benzotiazolInfo
- Publication number
- ECSP024399A ECSP024399A EC2002004399A ECSP024399A ECSP024399A EC SP024399 A ECSP024399 A EC SP024399A EC 2002004399 A EC2002004399 A EC 2002004399A EC SP024399 A ECSP024399 A EC SP024399A EC SP024399 A ECSP024399 A EC SP024399A
- Authority
- EC
- Ecuador
- Prior art keywords
- benzotiazol
- derivatives
- graph
- compounds
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
La presente invención se refiere a compuestos de la fórmula general (gráfico) y a las sales farmacéuticamente aceptables para el tratamiento de enfermedades relacionadas con el receptor de adenosina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00113219 | 2000-06-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP024399A true ECSP024399A (es) | 2003-02-06 |
Family
ID=8169041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2002004399A ECSP024399A (es) | 2000-06-21 | 2002-12-20 | Derivados de benzotiazol |
Country Status (34)
Country | Link |
---|---|
US (8) | US6521754B2 (es) |
EP (2) | EP1303272B1 (es) |
JP (1) | JP3886897B2 (es) |
KR (2) | KR100571161B1 (es) |
CN (1) | CN1234358C (es) |
AR (1) | AR031244A1 (es) |
AT (1) | ATE385794T1 (es) |
AU (2) | AU8181701A (es) |
BR (1) | BR0112395A (es) |
CA (1) | CA2413086C (es) |
CY (1) | CY1107401T1 (es) |
CZ (1) | CZ2003182A3 (es) |
DE (1) | DE60132777T2 (es) |
DK (1) | DK1303272T3 (es) |
EC (1) | ECSP024399A (es) |
ES (1) | ES2299504T3 (es) |
HK (1) | HK1058148A1 (es) |
HR (1) | HRP20020962A2 (es) |
HU (1) | HUP0301315A3 (es) |
IL (2) | IL153278A0 (es) |
JO (1) | JO2503B1 (es) |
MX (1) | MXPA02012596A (es) |
MY (1) | MY138352A (es) |
NO (2) | NO324635B1 (es) |
NZ (1) | NZ522928A (es) |
PE (1) | PE20020104A1 (es) |
PL (1) | PL207384B1 (es) |
PT (1) | PT1303272E (es) |
RU (1) | RU2251419C2 (es) |
SI (1) | SI1303272T1 (es) |
UY (1) | UY26782A1 (es) |
WO (1) | WO2001097786A2 (es) |
YU (1) | YU96502A (es) |
ZA (1) | ZA200209730B (es) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2299504T3 (es) * | 2000-06-21 | 2008-06-01 | F. Hoffmann-La Roche Ag | Derivados de benzotiazol para el tratamiento de la enfermedad de alzheimer y de la enfermedad de parkinson. |
US6620811B2 (en) | 2001-11-19 | 2003-09-16 | Hoffmann-La Roche Inc. | Isonicotin- and nicotinamide derivatives of benzothiazoles |
US6599901B1 (en) * | 2001-11-19 | 2003-07-29 | Hoffman-La Roche Inc. | Pyridone substituted benzothiazole derivatives |
CN1325052C (zh) | 2001-11-27 | 2007-07-11 | 弗·哈夫曼-拉罗切有限公司 | 苯并噻唑衍生物 |
US6624163B2 (en) | 2001-11-29 | 2003-09-23 | Hoffman-La Roche Inc. | Benzothiazole derivatives |
US6727247B2 (en) * | 2001-12-10 | 2004-04-27 | Hoffman-La Roche Inc. | Substituted benzothiazole amide derivatives |
JP4197649B2 (ja) * | 2001-12-12 | 2008-12-17 | エフ.ホフマン−ラ ロシュ アーゲー | アデノシン受容体モジュレーターとしてのベンゾチオフェン |
US6734179B2 (en) | 2001-12-12 | 2004-05-11 | Hoffmann-La Roche Inc. | Benzothiazoles |
US6713499B2 (en) * | 2001-12-12 | 2004-03-30 | Hoffman-La Roche Inc. | 7-Amino-benzothiazole derivatives |
ES2686123T3 (es) | 2002-01-28 | 2018-10-16 | Kyowa Hakko Kogyo Co., Ltd | Antagonistas del receptor A2A para su uso en el tratamiento de trastornos del movimiento |
ES2464157T3 (es) | 2002-06-26 | 2014-05-30 | Ono Pharmaceutical Co., Ltd. | Remedios para enfermedades causadas por contracción o dilatación vascular |
US6958420B2 (en) * | 2002-07-19 | 2005-10-25 | Board Of Trustees Of Michigan State University | Synthesis of aminoarylboronic esters and substituted anilines from arenes via catalytic C-H activation/borylation/amination and uses thereof |
US7338956B2 (en) | 2002-08-07 | 2008-03-04 | Sanofi-Aventis Deutschland Gmbh | Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
EA200500846A1 (ru) | 2002-11-19 | 2005-12-29 | Ачиллион Фармасьютикалз, Инк. | Замещенные арилтиомочевины и родственные соединения; ингибиторы вирусной репликации |
AR056615A1 (es) * | 2002-12-27 | 2007-10-17 | Kyowa Hakko Kogyo Kk | Un metodo de tratamiento de trastornos de la conducta |
US7087761B2 (en) * | 2003-01-07 | 2006-08-08 | Hoffmann-La Roche Inc. | Cyclization process for substituted benzothiazole derivatives |
CA2512602A1 (en) | 2003-01-13 | 2004-07-29 | F. Hoffmann-La Roche Ag | Benzoxazole derivatives and their use as adenosine receptor ligands |
US6872833B2 (en) * | 2003-04-14 | 2005-03-29 | Hoffmann-La Roche Inc. | Adenosine receptor ligands |
CN100372844C (zh) * | 2003-05-13 | 2008-03-05 | 弗·哈夫曼-拉罗切有限公司 | 作为腺苷受体配体的2-咪唑-苯并噻唑 |
RU2351597C2 (ru) * | 2003-05-19 | 2009-04-10 | Ф.Хоффманн-Ля Рош Аг | Производные бензотиазола в качестве лигандов аденозиновых рецепторов |
AU2004241720B2 (en) | 2003-05-21 | 2008-11-06 | F. Hoffmann-La Roche Ag | Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2A receptor |
NZ543372A (en) * | 2003-05-30 | 2008-11-28 | Hoffmann La Roche | Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenoside A2A receptor |
EA010017B1 (ru) * | 2003-07-10 | 2008-06-30 | Ачиллион Фармасьютикалз, Инк. | Замещённые арилтиомочевины, применимые в качестве ингибиторов репликации вирусов |
NZ544009A (en) * | 2003-07-24 | 2009-07-31 | Euro Celtique Sa | Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
MY174572A (en) | 2003-08-06 | 2020-04-27 | Firmenich Incorporated | Novel flavors, flavor modifiers, tastants, taste enhancers, umani or sweet tastants, and/or enhancers and use thereof |
KR20060058132A (ko) * | 2003-09-19 | 2006-05-29 | 에프. 호프만-라 로슈 아게 | 아데노신 수용체 리간드로서의 싸이아졸로피리딘 유도체 |
TW200600492A (en) * | 2004-05-18 | 2006-01-01 | Achillion Pharmaceuticals Inc | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
KR100834179B1 (ko) * | 2004-05-24 | 2008-05-30 | 에프. 호프만-라 로슈 아게 | 4-하이드록시-4-메틸-피페리딘-1-카복실산(4-메톡시-7-모폴린-4-일-벤조티아졸-2-일)-아마이드 |
SI1753760T1 (sl) * | 2004-05-24 | 2008-04-30 | Hoffmann La Roche | (4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid4- hidroksi-4-metil-piperidin-1-karboksilne kisline |
CN1989117B (zh) * | 2004-07-22 | 2011-01-19 | 弗·哈夫曼-拉罗切有限公司 | 取代的苯并噻唑 |
CA2574193C (en) * | 2004-07-22 | 2013-03-05 | F. Hoffmann-La Roche Ag | Benzothiazole derivatives as adenosine receptor ligands |
SE0401970D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Novel compounds |
ATE400557T1 (de) | 2004-11-05 | 2008-07-15 | Hoffmann La Roche | Verfahren zur herstellung von isonikotinsäurederivaten |
ATE460417T1 (de) | 2005-03-23 | 2010-03-15 | Hoffmann La Roche | Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten |
TWI370820B (en) | 2005-04-27 | 2012-08-21 | Takeda Pharmaceutical | Fused heterocyclic compounds |
EP1934214B1 (en) | 2005-09-27 | 2010-04-07 | F.Hoffmann-La Roche Ag | Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
ES2273599B1 (es) | 2005-10-14 | 2008-06-01 | Universidad De Barcelona | Compuestos para el tratamiento de la fibrilacion auricular. |
JP2009523748A (ja) * | 2006-01-18 | 2009-06-25 | シエナ ビオテク ソシエタ ペル アチオニ | α7ニコチン性アセチルコリン受容体の調節物質およびそれらの治療への使用 |
TWI425917B (zh) | 2006-04-21 | 2014-02-11 | Senomyx Inc | 包含高度鮮味風味劑之可食用組合物及其製造方法 |
US7429589B2 (en) | 2006-04-27 | 2008-09-30 | Hoffmann-La Roche Inc. | Mono-nitration of aromatic compounds via nitrate salts |
DE602007009221D1 (de) * | 2006-05-18 | 2010-10-28 | Hoffmann La Roche | Thiazolopyramidin/pyridinharnstoffderivate als antagonisten am adenosin-a2b-rezeptor |
GB0612428D0 (en) * | 2006-06-22 | 2006-08-02 | Prolysis Ltd | Antibacterial agents |
US8481544B2 (en) | 2006-06-22 | 2013-07-09 | Biota Europe Limited | Antibacterial compositions |
WO2008077809A1 (en) * | 2006-12-22 | 2008-07-03 | F. Hoffmann-La Roche Ag | Process for the manufacture of 7-oxa-bicyclo derivatives |
KR101516441B1 (ko) * | 2007-02-14 | 2015-05-07 | 바스프 에스이 | 전계발광 금속 착물 |
US20090176796A1 (en) * | 2007-04-27 | 2009-07-09 | Purdue Pharma L. P. | Trpv1 antagonists including amide substituent and uses thereof |
BRPI0814672A2 (pt) * | 2007-07-23 | 2014-09-30 | Synosia Therapeutics | Método de tratamento de um paciente, e de distúrbio de estresse pós-traumático, e, métodos para melhorar a resiliência em um paciente e para diagnosticar distúrbio de estresse pós-traumático em um paciente. |
US7913765B2 (en) * | 2007-10-19 | 2011-03-29 | Baker Hughes Incorporated | Water absorbing or dissolving materials used as an in-flow control device and method of use |
GB0724342D0 (en) | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
JO3101B1 (ar) | 2008-12-02 | 2017-09-20 | Takeda Pharmaceuticals Co | مشتقات بنزوثيازول كعوامل مضادة للسرطان |
KR101064258B1 (ko) | 2008-12-29 | 2011-09-14 | 한국과학기술연구원 | 벤조아릴우레이도 화합물, 및 이를 함유하는 퇴행성 뇌질환예방 또는 치료용 조성물 |
US8168785B2 (en) | 2009-06-17 | 2012-05-01 | Biotie Therapies, Inc. | Benzothiazole derivatives |
WO2010150927A1 (en) * | 2009-06-25 | 2010-12-29 | Sk Holdings Co., Ltd. | Pharmaceutical composition for prevention and treatment of cancer diseases comprising benzamide derivatives |
RU2455293C2 (ru) * | 2010-09-15 | 2012-07-10 | Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО ПГФА Росздрава) | N-(2-бензотиазолил)амид 3-бром-2,4-диоксо-4-(4-метоксифенил)бутановой кислоты, обладающий гипогликемической активностью |
RU2448100C1 (ru) * | 2010-09-24 | 2012-04-20 | Татьяна Николаевна Иванова | Производные 2-аминобензотиазола, обладающие противогипоксической активностью, и способ их использования |
US9000154B2 (en) * | 2010-10-19 | 2015-04-07 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
DE102011005232A1 (de) | 2011-03-08 | 2012-09-13 | AristoCon GmbH & Co. KG | Adenosin und seine Derivate zur Verwendung in der Schmerztherapie |
EP3173411B1 (en) | 2011-06-22 | 2018-05-09 | Purdue Pharma L.P. | Trpv1 antagonists including dihydroxy substituent and uses thereof |
TWI571466B (zh) * | 2011-10-14 | 2017-02-21 | 艾伯維有限公司 | 用於治療癌症及免疫與自體免疫疾病之細胞凋亡誘發劑 |
CN103772376B (zh) * | 2012-10-24 | 2017-01-11 | 中国医学科学院医药生物技术研究所 | 取代的苯并-1,3-杂唑类化合物、其制备方法及用途 |
WO2016025424A1 (en) | 2014-08-11 | 2016-02-18 | Angion Biomedica Corporation | Cytochrome p450 inhibitors and uses thereof |
EP3240778A4 (en) * | 2014-12-31 | 2018-07-11 | Angion Biomedica Corp. | Methods and agents for treating disease |
WO2017066225A1 (en) * | 2015-10-14 | 2017-04-20 | Texas Tech University System | Pharmacoperones of the v2 receptor |
US11597708B2 (en) | 2016-09-16 | 2023-03-07 | Hsf Pharmaceuticals Sa | Inhibitors of heat shock factors and uses thereof |
US11186592B2 (en) * | 2017-08-01 | 2021-11-30 | Merck Patent Gmbh | Thiazolopyridine derivatives as adenosine receptor antagonists |
BR112020006185A2 (pt) * | 2017-09-28 | 2020-10-13 | Cstone Pharmaceuticals (Suzhou) Co., Ltd. | derivado de anel fundido utilizado como inibidor de receptor a2a |
AR117844A1 (es) * | 2019-01-22 | 2021-09-01 | Merck Patent Gmbh | Derivados de tiazolopiridina como antagonistas del receptor de adenosina |
DE102019110904B4 (de) * | 2019-04-26 | 2022-01-20 | Helmholtz-Zentrum Dresden - Rossendorf E. V. | N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung |
EP4077320A4 (en) * | 2019-12-16 | 2024-01-03 | The University of British Columbia | ANTIVIRAL COMPOUNDS, COMPOSITIONS AND METHODS OF USE |
WO2021247921A1 (en) * | 2020-06-03 | 2021-12-09 | Yumanity Therapeutics, Inc. | Benzothiazole compounds and uses thereof |
WO2022164135A1 (ko) * | 2021-01-29 | 2022-08-04 | 한국화학연구원 | 벤조티아졸 및 벤즈이미다졸 유도체, 약제학적으로 허용 가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH505543A (de) * | 1968-11-01 | 1971-04-15 | Ciba Geigy Ag | Schädlingsbekämpfungsmittel |
GB1318291A (en) * | 1970-04-15 | 1973-05-23 | Shell Int Research | Carboxamide derivatives and fungicidal compositions containing them |
NL7109150A (es) * | 1970-07-06 | 1972-01-10 | ||
JPS5516147B2 (es) * | 1971-12-24 | 1980-04-30 | ||
US4028374A (en) * | 1975-11-03 | 1977-06-07 | Morton-Norwich Products, Inc. | Antibacterial thiocyanatobenzothiazoles |
DE2656468A1 (de) * | 1976-12-14 | 1978-06-15 | Boehringer Mannheim Gmbh | N-(benzthiazol-2-yl)-oxamidsaeure- derivate und verfahren zu ihrer herstellung |
US4471957A (en) * | 1979-12-03 | 1984-09-18 | Baltimore Therapeutic Equipment Company | Method and apparatus for rehabilitation of damaged limbs |
CA1153867A (en) | 1980-05-16 | 1983-09-20 | Michael A. M. Boersma | Process for the preparation of crystalline silicates, crystalline silicates so prepared and process for carrying out catalytic reactions |
KR930005004B1 (ko) * | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
FI91859C (fi) | 1987-06-17 | 1994-08-25 | Eisai Co Ltd | Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi |
EP0300688A1 (en) * | 1987-07-21 | 1989-01-25 | FISONS plc | Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them |
US5348519A (en) * | 1988-02-04 | 1994-09-20 | Loredan Biomedical, Inc. | Exercise and diagnostic apparatus and method |
IL90337A0 (en) * | 1988-05-24 | 1989-12-15 | Pfizer | Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents |
JPH0667923B2 (ja) | 1989-05-11 | 1994-08-31 | 東洋紡績株式会社 | 新規なベンゾチアゾール誘導体 |
WO1990015801A1 (en) * | 1989-06-22 | 1990-12-27 | Pfizer Inc. | Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases |
DE59005183D1 (de) | 1989-11-10 | 1994-05-05 | Agrolinz Agrarchemikalien | Verfahren zur Herstellung reiner, unsymmetrisch disubstituierter Harnstoffe. |
US5142910A (en) * | 1990-06-27 | 1992-09-01 | Occupational Orthopaedic Systems, Inc. | Dynamic physiological function testing apparatus and method |
EP0553130B1 (en) * | 1990-10-15 | 1996-01-03 | Pfizer Inc. | Pyrrolidine dione derivatives |
US5275045A (en) * | 1991-03-07 | 1994-01-04 | Isotechnologies, Inc. | Apparatus and method for use in assessing the lifting capability of a human subject |
MX9202022A (es) * | 1991-05-01 | 1992-11-01 | Otsuka Pharma Co Ltd | Derivados de pirazina y proceso para su preparacion. |
DK0604657T3 (da) * | 1992-05-21 | 2000-04-17 | Otsuka Pharma Co Ltd | Phosphonsyrediesterderivat |
US5312107A (en) * | 1993-05-13 | 1994-05-17 | Kordun, Ltd. | Golf club swing training and exercise device |
JPH0725858A (ja) * | 1993-07-13 | 1995-01-27 | Otsuka Pharmaceut Co Ltd | ピペラジン誘導体 |
JPH0940646A (ja) * | 1995-07-27 | 1997-02-10 | Yamanouchi Pharmaceut Co Ltd | ベンゼン縮合環誘導体又はその塩 |
FR2753970B1 (fr) * | 1996-10-01 | 1998-10-30 | Synthelabo | Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique |
JPH11130761A (ja) * | 1997-10-24 | 1999-05-18 | Otsuka Pharmaceut Co Ltd | ベンゾチアゾール誘導体 |
WO1999024035A1 (en) * | 1997-11-10 | 1999-05-20 | Bristol-Myers Squibb Company | Benzothiazole protein tyrosine kinase inhibitors |
WO1999031096A1 (en) * | 1997-12-18 | 1999-06-24 | Shaman Pharmaceuticals, Inc. | Piperazine derivatives useful as hypoglycemic agents |
CN1288462A (zh) * | 1998-01-23 | 2001-03-21 | 法玛西雅厄普约翰美国公司 | 噁唑烷酮组合库、组合物和制备方法 |
EP1117663A2 (en) | 1998-09-30 | 2001-07-25 | Neurogen Corporation | 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
UA71587C2 (uk) * | 1998-11-10 | 2004-12-15 | Шерінг Акцієнгезелльшафт | Аміди антранілової кислоти та їхнє застосування як лікарських засобів |
JP2002533453A (ja) * | 1998-12-23 | 2002-10-08 | イーライ・リリー・アンド・カンパニー | Xa因子のインヒビターとしてのヘテロ芳香族アミド |
IL133680A0 (en) * | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
CA2393825A1 (en) * | 1999-12-17 | 2001-06-21 | Versicor, Inc. | Novel succinate compounds, compositions and methods of use and preparation |
ES2299504T3 (es) * | 2000-06-21 | 2008-06-01 | F. Hoffmann-La Roche Ag | Derivados de benzotiazol para el tratamiento de la enfermedad de alzheimer y de la enfermedad de parkinson. |
US6620811B2 (en) * | 2001-11-19 | 2003-09-16 | Hoffmann-La Roche Inc. | Isonicotin- and nicotinamide derivatives of benzothiazoles |
US6727247B2 (en) * | 2001-12-10 | 2004-04-27 | Hoffman-La Roche Inc. | Substituted benzothiazole amide derivatives |
-
2001
- 2001-06-08 ES ES01960284T patent/ES2299504T3/es not_active Expired - Lifetime
- 2001-06-08 DK DK01960284T patent/DK1303272T3/da active
- 2001-06-08 CZ CZ2003182A patent/CZ2003182A3/cs unknown
- 2001-06-08 SI SI200130813T patent/SI1303272T1/sl unknown
- 2001-06-08 AU AU8181701A patent/AU8181701A/xx active Pending
- 2001-06-08 DE DE60132777T patent/DE60132777T2/de not_active Expired - Lifetime
- 2001-06-08 PT PT01960284T patent/PT1303272E/pt unknown
- 2001-06-08 KR KR1020027017432A patent/KR100571161B1/ko not_active IP Right Cessation
- 2001-06-08 BR BR0112395-5A patent/BR0112395A/pt not_active IP Right Cessation
- 2001-06-08 NZ NZ522928A patent/NZ522928A/en unknown
- 2001-06-08 CA CA2413086A patent/CA2413086C/en not_active Expired - Fee Related
- 2001-06-08 EP EP01960284A patent/EP1303272B1/en not_active Expired - Lifetime
- 2001-06-08 WO PCT/EP2001/006506 patent/WO2001097786A2/en active IP Right Grant
- 2001-06-08 AU AU2001281817A patent/AU2001281817B2/en not_active Ceased
- 2001-06-08 EP EP07003532A patent/EP1797878A3/en not_active Withdrawn
- 2001-06-08 HU HU0301315A patent/HUP0301315A3/hu unknown
- 2001-06-08 MX MXPA02012596A patent/MXPA02012596A/es active IP Right Grant
- 2001-06-08 JP JP2002503263A patent/JP3886897B2/ja not_active Expired - Fee Related
- 2001-06-08 PL PL360697A patent/PL207384B1/pl not_active IP Right Cessation
- 2001-06-08 IL IL15327801A patent/IL153278A0/xx unknown
- 2001-06-08 CN CNB018115349A patent/CN1234358C/zh not_active Expired - Fee Related
- 2001-06-08 YU YU96502A patent/YU96502A/sh unknown
- 2001-06-08 KR KR10-2005-7002723A patent/KR100526487B1/ko not_active IP Right Cessation
- 2001-06-08 RU RU2003100518/15A patent/RU2251419C2/ru not_active IP Right Cessation
- 2001-06-08 AT AT01960284T patent/ATE385794T1/de active
- 2001-06-14 JO JO200194A patent/JO2503B1/en active
- 2001-06-14 US US09/881,252 patent/US6521754B2/en not_active Expired - Fee Related
- 2001-06-18 PE PE2001000587A patent/PE20020104A1/es not_active Application Discontinuation
- 2001-06-19 MY MYPI20012891A patent/MY138352A/en unknown
- 2001-06-19 AR ARP010102899A patent/AR031244A1/es unknown
- 2001-06-20 UY UY26782A patent/UY26782A1/es not_active Application Discontinuation
-
2002
- 2002-11-29 ZA ZA200209730A patent/ZA200209730B/en unknown
- 2002-12-04 IL IL153278A patent/IL153278A/en not_active IP Right Cessation
- 2002-12-05 US US10/310,508 patent/US6835732B2/en not_active Expired - Fee Related
- 2002-12-05 HR HR20020962A patent/HRP20020962A2/xx not_active Application Discontinuation
- 2002-12-12 NO NO20025978A patent/NO324635B1/no not_active IP Right Cessation
- 2002-12-18 US US10/322,272 patent/US6963000B2/en not_active Expired - Fee Related
- 2002-12-20 EC EC2002004399A patent/ECSP024399A/es unknown
-
2004
- 2004-02-12 HK HK04100949A patent/HK1058148A1/xx not_active IP Right Cessation
- 2004-08-30 US US10/930,361 patent/US20050026906A1/en not_active Abandoned
-
2005
- 2005-09-02 US US11/219,577 patent/US7317007B2/en not_active Expired - Lifetime
-
2007
- 2007-07-06 NO NO20073465A patent/NO20073465L/no not_active Application Discontinuation
- 2007-10-31 US US11/930,717 patent/US20080125419A1/en not_active Abandoned
- 2007-10-31 US US11/930,799 patent/US20080108809A1/en not_active Abandoned
-
2008
- 2008-04-18 CY CY20081100435T patent/CY1107401T1/el unknown
-
2009
- 2009-12-01 US US12/628,243 patent/US20100075959A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP024399A (es) | Derivados de benzotiazol | |
UY26872A1 (es) | Derivados de la 4- fenil piridina | |
PA8544901A1 (es) | Derivados de oxazol | |
PA8578601A1 (es) | Derivados de 2,2- difenil-benzodioxol | |
GT200100137A (es) | Pro-drogas de derivados de 4-fenil-piridina. | |
TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
UY26968A1 (es) | Agentes terapéuticos | |
CR6726A (es) | Compuestos azapoliciclicos condensados con arilo | |
UY27714A1 (es) | 2 - heteroaril - pirimidinas inhibidoras de cdk, su preparación y su uso como medicamentos. | |
ECSP034744A (es) | Antagonistas de nmda/nr2b no arilo-heterociclico n-sustituidos | |
ES2161290T3 (es) | Derivados de quinazolina. | |
ECSP066643A (es) | PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS COMO INHIBIDORES DE PDE 2 | |
CR8102A (es) | Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa | |
CR6881A (es) | Derivados de pirazol | |
PA8547701A1 (es) | Nucleosidos 4 substituidos. | |
PA8442001A1 (es) | Derivados de pirimidina biciclica condensada | |
AR077478A2 (es) | Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos | |
PA8507601A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
UY30025A1 (es) | Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
PA8451801A1 (es) | Derivados de la 9-oxima eritromicina | |
NO20032208D0 (no) | Benzodiazepinderivater som GABA A reseptormodulatorer | |
UY29893A1 (es) | Derivados de pirazina | |
HN2003000272A (es) | Formulaciones que comprenden un compuesto de indolinona | |
HN2003000379A (es) | Derivados de anilinopirazol utiles en el tratamiento de la diabetes |